All Sections
Scotland's National Newspaper
Edit Account-Sign Out
My AccountSign Out
BREAKING
1 day ago Paul O’Grady’s final radio show to be rebroadcast on Easter Sunday
20 hours ago Gladiators legend dies aged 59 after cancer battle
21 hours ago Heathrow security staff start 10-day strike affecting Easter travels
21 hours ago Tributes pour as dad and son shot dead six-miles apart are named
23 hours ago Rotten meat in supermarkets report sparks national probe
23 hours ago Paul O’Grady’s husband shares the last picture they took together

ReNeuron shares surge on test results

SHARES in ReNeuron, the tiny Aim-listed life science company carrying out stem cell trials in Glasgow, jumped 5.4 per cent yesterday after the firm announced the successful completion of its initial tests.

By The Newsroom
Published 20th Dec 2010, 21:24 BST
Updated 21st Dec 2010, 22:07 BST

The company, whose stock posted a 60 per cent jump last month after starting trials at the Southern General Hospital, wants to use stem cells to treat stroke patients.

An independent data safety monitoring board met to review the status of the first patient in the trial 28 days after the treatment.

Hide Ad
Hide Ad

The board decided that ReNeuron can now continue with its trial using a further three patients.

Chief executive Michael Hunt said: "We are delighted that the stroke clinical trial will now move forward to the next milestone. It is both encouraging and reassuring to hear that no safety issues have been observed."